Vanguard Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Vanguard Capital Management's RGEN Position: Q3 2026 in Review
Vanguard Capital Management increased its Repligen (RGEN) stake by 1.3% in Q3 2026, buying an estimated $5.13M and bringing the position to 2,442,741 shares worth $470M. The position accounts for 0.01% of the portfolio, ranked #698.
Vanguard Capital Management first reported a position in RGEN in Q1 2026 and has held it in 3 quarters since. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Vanguard Capital Management held 2,442,741 shares of Repligen worth $470M as of Q3 2026.
- Vanguard Capital Management bought 31,570 Repligen shares in Q3 2026, an estimated $5.13M.
- Repligen made up 0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #698 holding.
- Vanguard Capital Management first reported a position in Repligen in Q1 2026 and has held it in 3 quarters since.
- 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.